Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients

SGLT2 inhibitors (SGLT2i) are now the mainstay therapy for both diabetes and heart failure. Post-hoc publications, meta-analysis, and conference presentations of the eight SGLT2i Cardiovascular Outcomes trials (CVOTS) done in diabetic patients constantly echo that this class of drug decreases mortal...

Descripción completa

Detalles Bibliográficos
Autor principal: Lam-Chung, Cesar Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400285/
https://www.ncbi.nlm.nih.gov/pubmed/37547306
http://dx.doi.org/10.3389/fendo.2023.1174692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400285/
https://www.ncbi.nlm.nih.gov/pubmed/37547306
http://dx.doi.org/10.3389/fendo.2023.1174692

Ejemplares similares